Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162.

Trial Profile

Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Jul 2016

At a glance

  • Drugs V 0162 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top